284 related articles for article (PubMed ID: 27031192)
1. Adnexal masses requiring reoperation in women with previous hysterectomy with or without adnexectomy.
Shiber LD; Gregory EJ; Gaskins JT; Biscette SM
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():123-7. PubMed ID: 27031192
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Outcomes after Single-port Laparoscopic Removal of Adnexal Masses in Patients Referred to Gynecologic Oncology at a Large Academic Center.
Moulton LJ; Jernigan AM; Michener CM
J Minim Invasive Gynecol; 2017; 24(7):1136-1144. PubMed ID: 28673874
[TBL] [Abstract][Full Text] [Related]
3. Mini-Laparoscopy for Removal (Partial) of Adnexae at the Time of Hysterectomy.
Setúbal AG; Alves JS; Lavado O; Faria J
J Minim Invasive Gynecol; 2017 Feb; 24(2):201-202. PubMed ID: 27856389
[TBL] [Abstract][Full Text] [Related]
4. Single-port laparoscopy in gynecologic oncology: seven years of experience at a single institution.
Moulton L; Jernigan AM; Carr C; Freeman L; Escobar PF; Michener CM
Am J Obstet Gynecol; 2017 Nov; 217(5):610.e1-610.e8. PubMed ID: 28619688
[TBL] [Abstract][Full Text] [Related]
5. Incidental occurrence of high grade serous tubal adenocarcinoma after prophylactic adnexectomy in benign gynecological surgery.
Kozolková D; Spodniaková B; Hajduková M; Hollý I; Záhumenský J
Ceska Gynekol; 2020; 85(2):111-115. PubMed ID: 32527104
[TBL] [Abstract][Full Text] [Related]
6. Tips and Tricks for Performing Salpingectomy at the Time of Laparoscopic Hysterectomy.
Stuparich MA; Lee TTM
J Minim Invasive Gynecol; 2017 Feb; 24(2):205. PubMed ID: 27956107
[TBL] [Abstract][Full Text] [Related]
7. Predictors of clinical outcomes in the laparoscopic management of adnexal masses.
Havrilesky LJ; Peterson BL; Dryden DK; Soper JT; Clarke-Pearson DL; Berchuck A
Obstet Gynecol; 2003 Aug; 102(2):243-51. PubMed ID: 12907095
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
[TBL] [Abstract][Full Text] [Related]
9. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
[TBL] [Abstract][Full Text] [Related]
11. The post-reproductive Fallopian tube: better removed?
Dietl J; Wischhusen J; Häusler SF
Hum Reprod; 2011 Nov; 26(11):2918-24. PubMed ID: 21849300
[TBL] [Abstract][Full Text] [Related]
12. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and the risk for malignancy in postmenopausal women with adnexal torsion.
Ganer Herman H; Shalev A; Ginath S; Kerner R; Keidar R; Bar J; Sagiv R
Maturitas; 2015 May; 81(1):57-61. PubMed ID: 25804950
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Cadish LA; Shepherd JP; Barber EL; Ridgeway B
Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
[TBL] [Abstract][Full Text] [Related]
15. Effects of hysterectomy with simultaneous bilateral salpingectomy on the subsequent pelvic mass.
Chao X; Wang X; Xiao Y; Ji M; Wang S; Shi H; Fan Q; Zhu L; Leng J; Sun D; Lang J
J Ovarian Res; 2019 Mar; 12(1):27. PubMed ID: 30917839
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.
Vorwergk J; Radosa MP; Nicolaus K; Baus N; Jimenez Cruz J; Rengsberger M; Gajda M; Diebolder H; Runnebaum IB
J Cancer Res Clin Oncol; 2014 May; 140(5):859-65. PubMed ID: 24573653
[TBL] [Abstract][Full Text] [Related]
17. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
18. Persistence of fimbrial tissue on the ovarian surface after salpingectomy.
Gan C; Chenoy R; Chandrasekaran D; Brockbank E; Hollingworth A; Vimplis S; Lawrence AC; Jeyarajah AR; Oram D; Deo N; Saravanamuthu J; Lam SS; Faruqi A; Singh N; Manchanda R
Am J Obstet Gynecol; 2017 Oct; 217(4):425.e1-425.e16. PubMed ID: 28610900
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Value of Prophylactic Salpingectomy in Hysterectomy due to Uterine Benign Lesions].
Zhao LJ; Wang P; Li XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):314-317. PubMed ID: 28612548
[TBL] [Abstract][Full Text] [Related]
20. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
